Breast MRI Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Systems, Coils, Software), By Imaging Technique/Contrast Use (Contrast-enhanced MRI, Non-contrast/Abbreviated), By Condition (Malignant, Benign), By End-use, By Region, And Segment Forecasts

Breast MRI Market Summary

The global breast MRI market size was valued at USD 2.30 billion in 2024 and is projected to reach USD 5.28 billion by 2033, growing at a CAGR of 9.70% from 2025 to 2033. The demand for breast MRI is rising owing to the advancements in MRI technology and the growing burden of breast cancer.

In addition, growing awareness and screening initiatives for breast cancer are anticipated to drive market growth in the coming years. The rising global burden of breast cancer is a significant factor driving the growth of the breast MRI market. Breast magnetic resonance imaging is widely used to detect additional cancerous areas within the breast and serves as a critical screening tool for individuals at high risk of developing breast cancer. According to data released by the World Health Organization in February 2025, approximately 1 in 20 women worldwide will be diagnosed with breast cancer during their lifetime. If current trends persist, the number of new breast cancer cases is projected to reach 3.2 million annually by 2050, accompanied by 1.1 million deaths related to the disease each year. In 2022 alone, an estimated 2.3 million new breast cancer cases and 670,000 related deaths were reported globally. This increasing prevalence of breast cancer is expected to significantly boost the demand for breast MRI throughout the forecast period.

In addition to the global rise in breast cancer cases, several key regions-including Asia, Europe, North America, and Latin America-are experiencing significant prevalence of the disease. The graph below highlights the growing regional burden of breast cancer, illustrating the predicted incidence rates by 2030.

This substantial regional burden underscores the growing need for advanced diagnostic tools like breast magnetic resonance imaging, which plays a vital role in early detection, comprehensive assessment, and effective management of breast cancer. As a result, these regional trends are expected to strongly contribute to the expansion of the breast MRI market over the coming years.

“Every minute, four women are diagnosed with breast cancer worldwide and one woman dies from the disease, and these statistics are worsening,” says IARC scientist Dr. Joanne Kim.

Key Opinion Leaders

Source: Grand View Research Analysis

Market Concentration & Characteristics

The market growth stage is high, and the pace of growth is accelerating. The breast MRI market is characterized by high growth owing to the rising burden of breast cancer, and advancements in magnetic resonance imaging technology.

Industry players and researchers are increasingly focusing on the advanced breast MRI industry. Several clinical trials are ongoing in this industry. For instance, in February 2024, the University of Massachusetts, Worcester, initiated a clinical trial involving 200 enrollments to compare screening magnetic resonance imaging for high-risk breast cancer patients identified by Mirai and Tyrer-Cuzick. Such trials are anticipated to provide lucrative opportunities for innovation in the breast MRI industry.

Breast MRI regulations encompass guidelines related to patient preparation, imaging protocols, and interpretation to ensure accurate and safe breast cancer screening and diagnosis. Various regulatory bodies and professional organizations issue these guidelines to standardize practices. For example, in 2023, the Breast Imaging Society of India published the Quality Assurance Guidelines for Breast Imaging, which address critical aspects of breast MRI, including:

• Equipment specifications

• Timing and imaging techniques

• Quality assurance protocols for equipment

• Qualifications and responsibilities of radiologists

• Qualifications and responsibilities of technologists

Such guidelines play a significant role in shaping the breast MRI market by promoting high standards of practice, improving diagnostic accuracy, and enhancing patient safety.

Mergers and acquisitions play a pivotal role in the breast MRI industry, allowing companies to broaden their product portfolios, enhance technological capabilities, and improve market competitiveness. Through strategic acquisitions, leading players can integrate advanced imaging solutions, streamline diagnostics, and strengthen their position in the growing breast imaging sector, ultimately driving innovation and expanding global reach.

Product Insights

The systems segment led the market in 2024, accounting for a dominant revenue share of 75.44%, and is expected to maintain its strong position over the forecast period. This leadership is attributed to the growing adoption of technologically advanced MRI systems and continuous innovation in imaging capabilities. For instance, in February 2025, researchers at the University of Waterloo introduced a new form of magnetic resonance imaging enhanced with artificial intelligence (AI). This innovation enables cancerous tissue to appear illuminated or “glowing” next to healthy tissue in breast magnetic resonance imaging scans, significantly improving visibility and diagnostic accuracy. Such advancements are expected to drive the demand for high-performance MRI systems, particularly those equipped with AI-powered image enhancement tools.

The coils segment is projected to be the fastest-growing segment, driven by continuous innovation and advancements in MRI coil technology. For example, in February 2025, an Austrian study highlighted the benefits of supine breast magnetic resonance imaging using a lightweight, wearable radiofrequency coil vest (BraCoil), which demonstrated improved lesion localization compared to traditional prone imaging. This coil provides more accurate lesion positioning relative to ultrasound and is expected to boost the adoption of next-generation coil systems significantly, propelling segment growth in the years ahead.

Imaging Technique / Contrast Use Insights

The Contrast-Enhanced MRI (CE-MRI) segment dominated the market in 2024, supported by increasing approvals of contrast agents tailored for breast imaging. For instance, Guerbet’s Elucirem (Gadopiclenol) received European Commission approval in December 2023. This macrocyclic gadolinium-based contrast agent is indicated for use in breast and other organ imaging. Such innovations enhance diagnostic precision and expand clinical applications, making CE-MRI a preferred modality and driving the continued growth of this segment in the global breast MRI market.

The Non-Contrast / Abbreviated Breast MRI (Ab-MRI) segment is expected to experience the fastest growth from 2025 to 2033, driven by increasing demand for safer imaging options, particularly among patients with kidney problems or sensitivities to contrast agents. Additionally, supportive clinical evidence is fueling this growth. A 2022 study published by the National Library of Medicine found that a non-contrast magnetic resonance imaging technique using short tau inversion recovery diffusion-weighted imaging (STIR-DWI) demonstrated diagnostic accuracy comparable to dynamic contrast-enhanced MRI (DCE-MRI) in distinguishing benign from malignant lesions in BI-RADS category 0 cases.

End-use Insights

The hospitals and clinics segment dominated the market in 2024, capturing the largest share of 42.46%. This dominance is driven by the widespread availability of advanced imaging infrastructure, the presence of skilled radiologists, and higher patient inflow for diagnostic procedures in hospital settings. In addition, hospitals and clinics are often the primary centers for cancer screening, early diagnosis, and treatment planning, making them key contributors to breast magnetic resonance imaging utilization worldwide.

The breast care centers segment is expected to register the highest CAGR from 2025 to 2033, driven by the growing demand for specialized, patient-centered care in breast health. These centers offer comprehensive diagnostic services, including advanced MRI imaging, often integrated with screening, biopsy, and follow-up care. Increased awareness, early detection initiatives, and the rising prevalence of breast cancer are further accelerating the segment’s growth.

Condition Insights

The malignant segment dominated the market in 2024, capturing the largest share of 84.18%. It is also anticipated to grow fastest, driven by the high prevalence of breast cancer worldwide. Breast magnetic resonance imaging is widely used for accurate detection, characterization, and staging of malignant tumors, enabling early diagnosis and treatment planning. The increasing incidence of breast cancer, along with growing awareness and adoption of advanced imaging techniques, continues to fuel demand for breast MRI in malignant lesion evaluation.

The benign segment is projected to witness significant growth in the breast MRI market from 2025 to 2033, driven by rising awareness of breast health and the increasing need for precise differentiation between benign and malignant lesions. Technological advancements in imaging and the growing use of magnetic resonance imaging for monitoring and evaluating benign breast conditions further support the segment’s expansion during the forecast period.

Regional Insights

North America breast MRI market held the largest revenue share of 44.79% in 2024. The region is also projected to grow at the fastest rate over the forecast period, fueled by the strong presence of key industry players such as GE Healthcare, Siemens Healthineers, and Philips Healthcare, as well as continuous product innovation. Additionally, the region benefits from well-established MRI infrastructure and high adoption of advanced imaging technologies. For instance, in Canada alone, approximately 2,214,157 publicly funded MRI examinations were conducted during the 2022-2023 fiscal year, reflecting the scale of imaging utilization. These factors are expected to significantly propel the growth of the breast MRI market across North America.

U.S. Breast MRI Market Trends

The breast MRI market in the U.S. is poised for robust growth, driven by the presence of leading industry players, strategic collaborations, and a growing number of research initiatives and clinical trials focused on breast MRI applications. Additionally, supportive government regulations and healthcare policies are further contributing to market expansion by promoting advanced diagnostic imaging and facilitating broader access to breast MRI services across the country.

Europe Breast MRI Market Trends

The breast MRI market in Europe is experiencing constant growth, driven by rising breast cancer incidence, heightened awareness of early detection, and strong governmental backing for national screening programs. The region benefits from a well-developed healthcare infrastructure and increasing adoption of non-invasive imaging technologies. Favorable clinical guidelines and policy support further propel market expansion. For instance, in March 2022, the European Society of Breast Imaging (EUSOBI) suggested breast MRI screening for women with extremely dense breast tissue, reinforcing the clinical value and demand for advanced imaging modalities across Europe.

The UK breast MRI market is expected to experience substantial growth in the coming years, driven by increasing awareness of breast density and its impact on cancer detection. Additionally, the presence of influential organizations such as Cancer Research UK, which actively promotes early diagnosis and advanced imaging research, further supports the adoption of breast MRI across the country.

Asia Pacific Breast MRI Market Trends

The breast MRI market in Asia Pacific is projected to experience substantial growth throughout the forecast period, fueled by a range of key factors. One of the primary drivers is the increasing prevalence of breast cancer across the region, which has led to a larger patient base requiring advanced diagnostic imaging solutions. Additionally, heightened awareness about breast cancer screening and early detection is encouraging more women to undergo MRI procedures. Furthermore, industry players are intensifying their focus on emerging economies like India and China, where improving healthcare infrastructure and rising disposable incomes are boosting demand for sophisticated medical imaging technologies. Government initiatives and public health campaigns aimed at promoting breast cancer awareness and facilitating access to diagnostic services are also contributing to market expansion.

India breast MRI market is anticipated to witness significant growth during the forecast period, driven by the rising incidence of breast cancer and increased awareness of early detection. Government initiatives, such as Voxelgrids Innovations’ development of an MRI scanner under the National Biopharma Mission in August 2023, are enhancing access to advanced diagnostic technologies. Additionally, expanding healthcare infrastructure and growing industry focus on emerging markets like India are fueling demand for breast MRI, supporting improved diagnosis and treatment outcomes.

Latin America Breast MRI Market Trends

The breast MRI market in Latin America is experiencing steady growth, propelled by a rising prevalence of breast conditions and ongoing improvements in healthcare infrastructure. Moreover, technological advancements in MRI and increased accessibility in countries such as Brazil are further driving market expansion, supporting earlier diagnosis and better treatment outcomes.

Middle East and Africa Breast MRI Market Trends

The breast MRI market in the Middle East and Africa is experiencing steady growth, driven by rising breast cancer cases and expanding healthcare infrastructure. For instance, in April 2025, Burjeel Cancer Institute (BCI) in the UAE launched the Burjeel Breast Center, a facility providing comprehensive care for breast conditions, enhancing diagnostic and treatment capabilities. Such advancements and improved access to advanced MRI technology are boosting market demand across the region.

Saudi Arabia breast MRI market is expected to experience significant market growth, driven by the rising prevalence of breast cancer, increased government investments in healthcare infrastructure, and growing awareness of early detection. The adoption of advanced MRI technologies, along with initiatives to enhance cancer screening programs, is further fueling demand and improving diagnostic accuracy across the country.

Key Breast MRI Companies Insights

Key players operating in the breast MRI market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Recent Developments

• In April 2025, ScreenPoint Medical presented the advanced capabilities of its Breast AI system, Transpara, at the 2025 Society of Breast Imaging Symposium. The study titled "Multi-site Validation of a Novel AI System for Cancer Detection in Abbreviated Breast MRI," presented during this symposium, demonstrated the AI's effectiveness in detecting breast cancer using abbreviated DCE-MRI across multiple institutions. Results indicated that this AI system offers strong potential as a decision-support tool.

• In December 2024, GE HealthCare unveiled research on an advanced 3D MRI foundation model designed to integrate with clinical reporting standards like BI-RADS. This model leverages the detailed anatomical and pathological insights from 3D MRIs to improve the consistency, objectivity, and efficiency of breast cancer diagnosis and risk stratification by better characterizing breast lesions such as shape, size, and margins.

Breast MRI Market Report Scope

Global Breast MRI Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast MRI market report based on product, imaging technique/contrast use, condition, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Systems

    • By MRI System Type

      • Closed MRI Systems

      • Open MRI Systems

    • By Field Strength

      • 1.5 Tesla (1.5T)

      • 3 Tesla (3T)

      • 7 Tesla (7T)

    • By Dimensional Modality

      • 3D Breast MRI

      • 4D Breast MRI

  • Coils

    • By Coil Configuration

      • Unilateral Breast Coils

      • Bilateral Breast Coils

    • By Channel Count

      • 8-Channel Breast Coils

      • 16-Channel (or Higher) Breast Coils

    • By Functionality

      • Diagnostic-Only Coils

      • Biopsy-Compatible Breast Coils

  • Software

• Imaging Technique / Contrast Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Contrast-Enhanced MRI (CE-MRI)

  • Non-Contrast / Abbreviated Breast MRI (Ab-MRI)

• Condition Outlook (Revenue, USD Million, 2021 - 2033)

  • Malignant

  • Benign

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals and Clinics

  • Diagnostic Imaging Centers

  • Breast Care Centers

  • Academic & Research Institutes

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait